These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 18226000

  • 1. Treatment of nephrogenic systemic fibrosis: limited options but hope for the future.
    Linfert DR, Schell JO, Fine DM.
    Semin Dial; 2008; 21(2):155-9. PubMed ID: 18226000
    [Abstract] [Full Text] [Related]

  • 2. Dialytic therapies to prevent NSF following gadolinium exposure in high-risk patients.
    Rodby RA.
    Semin Dial; 2008; 21(2):145-9. PubMed ID: 18226002
    [Abstract] [Full Text] [Related]

  • 3. Nephrogenic systemic fibrosis and gadolinium-based contrast: medico-legal implications.
    Houck CM, Pristave RJ, Kannensohn KJ.
    Semin Dial; 2008; 21(2):166-70. PubMed ID: 18226003
    [Abstract] [Full Text] [Related]

  • 4. Nephrogenic systemic fibrosis: early recognition and treatment.
    Knopp EA, Cowper SE.
    Semin Dial; 2008; 21(2):123-8. PubMed ID: 18226008
    [Abstract] [Full Text] [Related]

  • 5. New insights into nephrogenic systemic fibrosis.
    Swaminathan S, Shah SV.
    J Am Soc Nephrol; 2007 Oct; 18(10):2636-43. PubMed ID: 17855637
    [Abstract] [Full Text] [Related]

  • 6. [Nephrogenic systemic fibrosis: another problem for patients with chronic renal failure].
    Michelet PR, Chopard CS, Martin PY, Vallée JP.
    Rev Med Suisse; 2008 Mar 05; 4(147):576-8, 580. PubMed ID: 18402015
    [Abstract] [Full Text] [Related]

  • 7. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD, Bernheisel CR.
    Am Fam Physician; 2009 Oct 01; 80(7):711-4. PubMed ID: 19817341
    [Abstract] [Full Text] [Related]

  • 8. Patient characteristics and risk factors for nephrogenic systemic fibrosis following gadolinium exposure.
    Grobner T, Prischl FC.
    Semin Dial; 2008 Oct 01; 21(2):135-9. PubMed ID: 18226001
    [Abstract] [Full Text] [Related]

  • 9. Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure.
    Deo A, Fogel M, Cowper SE.
    Clin J Am Soc Nephrol; 2007 Mar 01; 2(2):264-7. PubMed ID: 17699423
    [Abstract] [Full Text] [Related]

  • 10. Nephrogenic systemic fibrosis: what the hospitalist needs to know.
    Fine DM, Perazella MA.
    J Hosp Med; 2010 Jan 01; 5(1):46-50. PubMed ID: 20063400
    [Abstract] [Full Text] [Related]

  • 11. Nephrogenic systemic fibrosis and gadolinium-based contrast: what's a nephrologist to do?
    Perazella MA.
    Semin Dial; 2008 Jan 01; 21(2):121-2. PubMed ID: 18248521
    [No Abstract] [Full Text] [Related]

  • 12. UV-A1 therapy for nephrogenic systemic fibrosis.
    Tran KT, Prather HB, Cockerell CJ, Jacobe H.
    Arch Dermatol; 2009 Oct 01; 145(10):1170-4. PubMed ID: 19841406
    [Abstract] [Full Text] [Related]

  • 13. Extracorporeal photopheresis improves nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: three case reports and review of literature.
    Mathur K, Morris S, Deighan C, Green R, Douglas KW.
    J Clin Apher; 2008 Oct 01; 23(4):144-50. PubMed ID: 18633995
    [Abstract] [Full Text] [Related]

  • 14. Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness.
    Canavese C, Mereu MC, Aime S, Lazzarich E, Fenoglio R, Quaglia M, Stratta P.
    J Nephrol; 2008 Oct 01; 21(3):324-36. PubMed ID: 18587720
    [Abstract] [Full Text] [Related]

  • 15. Tissue deposition of gadolinium and development of NSF: a convergence of factors.
    Perazella MA.
    Semin Dial; 2008 Oct 01; 21(2):150-4. PubMed ID: 18226004
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
    Broome DR.
    Eur J Radiol; 2008 May 01; 66(2):230-4. PubMed ID: 18372138
    [Abstract] [Full Text] [Related]

  • 18. Nephrogenic systemic fibrosis: a nephrologist's perspective.
    Saab G, Cheng S.
    Hemodial Int; 2007 Oct 01; 11 Suppl 3():S2-6. PubMed ID: 17897106
    [Abstract] [Full Text] [Related]

  • 19. [Nephrogenic systemic fibrosis].
    Artunc F, Schanz S, Metze D, Heyne N.
    Dtsch Med Wochenschr; 2008 Oct 01; 133 Suppl():F1. PubMed ID: 18802876
    [Abstract] [Full Text] [Related]

  • 20. Nephrogenic systemic fibrosis risk: is there a difference between gadolinium-based contrast agents?
    Penfield JG, Reilly RF.
    Semin Dial; 2008 Oct 01; 21(2):129-34. PubMed ID: 18225999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.